Therapie des metastasierten Cholangiokarzinoms - Wikidata - wikimedia - TriplyDB

Therapie des metastasierten Cholangiokarzinoms

Therapie des metastasierten Cholangiokarzinoms

http://www.wikidata.org/entity/Q57074642

about

Therapie des metastasierten Cholangiokarzinoms

http://www.wikidata.org/entity/Q57074642

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2015

@uk

name

Therapie des metastasierten Cholangiokarzinoms

@en

Therapie des metastasierten Cholangiokarzinoms

@nl

type

label

Therapie des metastasierten Cholangiokarzinoms

@en

Therapie des metastasierten Cholangiokarzinoms

@nl

prefLabel

Therapie des metastasierten Cholangiokarzinoms

@en

Therapie des metastasierten Cholangiokarzinoms

@nl

P1476

Q57074642-88B8AECE-1648-42CA-BA9E-ADBDB4BE6F1A

P2093

Q57074642-1572972C-C51B-466D-B0BC-B7C335F3696A

Q57074642-259ED511-E1ED-4F7A-8840-392B8348717C

P2860

Q57074642-0244050A-C3C5-4A83-833E-BE3DEB04C6A6

Q57074642-0FC32565-980F-4959-98CE-7E286FA685DF

Q57074642-100E6A8A-BD9E-4263-B9B8-21C0EE95BAD5

Q57074642-378407AA-16AC-44AF-8E93-215084633544

Q57074642-38F56188-9EEE-474C-B309-2ECEC32A856C

Q57074642-3BBCC3FD-4216-4C38-AC3E-A8C6346F01D2

Q57074642-470F7E02-0CF7-4187-A9A8-098D9EDED8E4

Q57074642-48438EBF-95B3-42B0-A13E-6EB3E56B0BDC

Q57074642-59C6EC07-E829-47A7-9C9C-F1DDFDFC93E7

Q57074642-66FD318F-5B26-4DA2-B233-A0C1FEE26C52

P304

Q57074642-1D88DEC7-9ECA-4856-9CCC-9F53599385E0

P31

Q57074642-C16BFFD0-AB4E-421E-8F0F-E434D8B4FFF4

P356

Q57074642-D11A93DA-8202-4D48-95E0-2D0D8531B814

P433

Q57074642-3BB793AB-9DD3-47E3-8B7F-A18BFD8EB9E8

P478

Q57074642-0E322FEB-80DD-4CEA-96E0-6D2BD43A56B4

P577

Q57074642-0F59ADA3-695A-4FBA-91FE-09CEEA88AD54

P356

S00761-015-2932-2

P1476

Therapie des metastasierten Cholangiokarzinoms

@en

P2093

A. Vogel

http://www.w3.org/2001/XMLSchema#string

R.R. Plentz

http://www.w3.org/2001/XMLSchema#string

P2860

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer.

Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree.

A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer.

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: a multicentre, multinational study.

Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study.

HDAC6 inhibition restores ciliary expression and decreases tumor growth

Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials.

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.

P304

1064-1068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00761-015-2932-2

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime